Dr. Michel Azer’s Blog

May 10, 2026
Price is not the only objection: Overcoming uncertainty when selling elective dental procedures

Psychological uncertainty – regarding pain, aesthetics, and recovery – is a more significant barrier to elective dental case acceptance than price alone. This uncertainty dampens consumers' spending power by shifting elective dentistry from "desired self-improvement" to "financial and physical risk," causing patients to defer high-ticket items like implants and clear aligners in favor of preserving liquidity during periods of economic volatility. Shifting your consultation focus from "financing options" to "outcome certainty" (via 3D simulations and trial-wear) can bridge the 20% gap between diagnosis and acceptance, potentially adding $150k–$300k in annual production for a standard GP practice without increasing marketing spend.

Read More
May 9, 2026
Why Google Ads Keep Flooding Dental Practices With Patients Seeking Free Implants, Government Grants, or Trials

Sophisticated lead-generation networks are using clickbait "free dental implant" content to exploit Google’s advertising ecosystem, funneling low-quality inquiries to legitimate dental practices and inflating marketing costs. And here's why Google isn't doing anything about it.

Read More
May 8, 2026
Why patients are shopping more, hesitating longer, and asking about money earlier, and how this changes your sales approach.

Once, patients viewed dentistry as a trusted local service; many now treat it like any other retail purchase: they shop, compare, and negotiate. Forward-thinking practices that treat patients as informed buyers – offering upfront pricing, multiple financing tiers, and empathetic cost conversations – are converting more of the elective pipeline into completed care.

Read More
May 7, 2026
Why Financing Questions Are Showing Up Earlier in the Patient Journey

With Barclays forecasting no Federal Reserve rate cuts through 2026 and University of Michigan year-ahead inflation expectations surging from 3.8% to 4.7%, dental patients are now raising monthly-payment questions far earlier in the journey – often during the first call or website visit – for high-ticket elective procedures like implants, Invisalign, and cosmetic work. In this higher-for-longer borrowing environment, price-sensitive households are scrutinizing affordability before they ever reach the chair. Practice owners who move clear financing language upstream into ads, landing pages, phone scripts, and initial replies will capture more prospects, lift case acceptance on high-margin services, and protect revenue before competitors do.

Read More
May 6, 2026
The 2026 Dental Google Ads Crisis: Rising CPC & DSO Competition

Higher Google Ads CPCs directly inflate the cost of attracting elective patients for implants, Invisalign, whitening, and cosmetic work – procedures that often represent 40-60% of practice profit – potentially forcing fee increases, reduced marketing budgets, or lower chair utilization if volume cannot be maintained at previous ROI levels.

Read More
May 5, 2026
Colgate Q1 2026 Analysis: What Dental Practice Owners Need to Know

The 3.1% organic growth in oral care proves that your patient base is not cutting corners on home care; use this momentum to emphasize "preventive-to-procedural" transitions, as patients buying premium $8–$10 toothpaste are the primary candidates for elective whitening and high-end restorative work.

Read More
May 4, 2026
The Dental AI Gap: How Missed Calls Cost Practices $150k Annually

Dental teams are right to question overhyped tools that promise to replace clinical judgment. But when that caution keeps proven administrative AI off the front desk and out of the lead pipeline, practices are quietly forfeiting six-figure revenue every year.

Read More
May 3, 2026
Inflation’s Unexpected Reversal

Higher-for-longer interest rates will raise the cost of patient financing for elective dental procedures such as implants, Invisalign, whitening, and cosmetic work – services often funded through credit cards, CareCredit, or other third-party loans (aka Cherry) – eroding affordability and reducing case acceptance rates for non-urgent care.

Read More
May 2, 2026
The End of Easy Money

How Tight Credit Killed the Dental Roll-Up Boom, and Rewrote the Exit Playbook for Independent Dentists

Read More
May 2, 2026
Affordable Care, a Leading Dental Provider, Cannot Repay $1.4 Billion Loan From Blackstone, KKR and Other Private-Credit Lenders

Affordable Care’s debt restructuring signals financial pressure in cash-pay, elective dental models that rely heavily on demand for implants, dentures, and full-arch restorations. The takeaway is higher rates and weaker consumer spending is reshaping growth economics for dental practices.

Read More
* By calling, texting, or chatting with Microsite Health (DBA The Executive Whisper, LLC) or CRTX, you consent to receive responses by call and SMS from a CRTX AI Agent or a team member at the number you provide. Message & data rates may apply. Frequency varies. Reply STOP to opt out at any time. No spam. We do not sell your information. Consent is not a condition of purchase. See our Privacy Policy.
© 2025 The Executive Whisper LLC. DBA Microsite Health. Agent Marketing, CRTX, CRTX Brainwaves, and Microsite Health are trademarks of The Executive Whisper LLC. All rights reserved.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram